You searched for: Venous thromboembolism (VTE) risk assessment

13 results

Venous thromboembolism (VTE) risk assessment: Q1 2019/20

The venous thromboembolism (VTE) risk assessment data collection is used to inform a national quality requirement in the NHS Standard Contract for 2019/20, which sets an operational standard of 95% of inpatients (aged 16 and over at the time of admission) undergoing risk assessments each month. The official statistics for VTE risk assessment in England […]

Venous thromboembolism (VTE) risk assessment: Q2 2019/20

The venous thromboembolism (VTE) risk assessment data collection is used to inform a national quality requirement in the NHS Standard Contract for 2019/20, which sets an operational standard of 95% of inpatients (aged 16 and over at the time of admission) undergoing risk assessments each month. The official statistics for VTE risk assessment in England […]

Venous thromboembolism (VTE) risk assessment: Q3 2019/20

The venous thromboembolism (VTE) risk assessment data collection is used to inform a national quality requirement in the NHS Standard Contract for 2019/20, which sets an operational standard of 95% of inpatients (aged 16 and over at the time of admission) undergoing risk assessments each month. The official statistics for VTE risk assessment in England […]

Venous thromboembolism (VTE) risk assessment 2019/20

The number and proportion of admitted patients (aged 16 and over at the time of admission) in England who have been risk assessed for VTE in 2019/20. The VTE data collection and publication is currently suspended to release capacity in providers and commissioners to manage the COVID-19 pandemic. This was communicated via this letter on 28 […]

Assessment of risk of venous thromboembolism (VTE) when prescribing combined hormonal contraceptives

Through its review of recorded patient safety events, the National Patient Safety Team identified an issue where a patient sadly died after no assessment of lifestyle factors was made during a remote consultation, before being prescribed combined hormonal contraception (CHC). When taking CHC there is a small risk of VTE. This risk is increased in […]

Our major strides in preventing venous thromboembolism

Helen Morrison, National Venous Thromboembolism Prevention Programme Manager, reflects on the achievements of the VTE programme, ahead of talking in the House of Commons at the All-Party Parliamentary Thrombosis Group annual conference. Today I am speaking at the All-Party Parliamentary Thrombosis Group annual conference to provide an update on NHS England’s National Venous Thromboembolism (VTE) […]